Platelet and WBC disorders

Similar documents
Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

CHALLENGING CASES PRESENTATION

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Polycythemia Vera and other Myeloproliferative Neoplasms. A.Mousavi

Hematology: Challenging Cases with Your Participation COPYRIGHT

MYELODYSPLASTIC SYNDROMES

Beyond the CBC Report: Extended Laboratory Testing in the Evaluation for Hematologic Neoplasia Disclosure

Myeloproliferative Disorders: Diagnostic Enigmas, Therapeutic Dilemmas. James J. Stark, MD, FACP

MDS: Who gets it and how is it diagnosed?

Myeloproliferative Disorders - D Savage - 9 Jan 2002

Pathology. #11 Acute Leukemias. Farah Banyhany. Dr. Sohaib Al- Khatib 23/2/16

Heme 9 Myeloid neoplasms

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

2013 Pathology Student

Common Consultations in Outpatient Hematology in 30 mins. Lala Cornelius, MD

2013 AAIM Pathology Workshop

Clinical & Laboratory Assessment

Disclosures. Myeloproliferative Neoplasms: A Case-Based Approach. Objectives. Myeloproliferative Neoplasms. Myeloproliferative Neoplasms

Medical Surgical Review Handout- Hematology/Oncology 2016

Borderline cytopenias. Dr Taku Sugai Consultant Haematologist

Things to never miss in the office. Brett Houston MD FRCPC (PYG-5, hematology) Leonard Minuk MD FRCPC

Myelodysplastic syndrome (MDS) & Myeloproliferative neoplasms

Myelodysplastic Syndrome: Let s build a definition

Disorders of Blood Cells & Blood Coagulation

Chronic Idiopathic Myelofibrosis (CIMF)

Year 2003 Paper two: Questions supplied by Tricia

HEFT Pathology Guideline. GP Investigation and Referral Pathways for leucocyte, platelet disturbances and polycythaemia

5/5/2010. Goldilocks picture from

Hematologic Disorders. Assistant professor of anesthesia

HENATOLYMPHOID SYSTEM THIRD YEAR MEDICAL STUDENTS- UNIVERSITY OF JORDAN AHMAD T. MANSOUR, MD. Part 4 MYELOID NEOPLASMS

Warm Autoantibodies in a Patient with Hemophagocytic Lymphohistiocytosis: A Case Report

74y old Female with chronic elevation of Platelet count. August 18, 2005 Faizi Ali, MD Hematopathology Fellow

A Practical Approach to Leukopenia/Neutropenia in Children. Vandy Black, M.D., M.Sc., FAAP OLOL Children s Hospital August 24, 2014

The primary medical content categories of the blueprint are shown below, with the percentage assigned to each for a typical exam:

Clinical implications for decreased lymphocytes (lymphopenia) o Corticosteroid therapy, adrenocortical hyperfunction, stress, shock

Myelodysplastic Syndromes Myeloproliferative Disorders

Common Haematological Problems in Primary Care

Interpreting an Abnormal CBC

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

Myeloid neoplasms. Early arrest in the blast cell or immature cell "we call it acute leukemia" Myoid neoplasm divided in to 3 major categories:

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

SB 6331 (scanned slide available) Keith Duncan; Mills-Peninsula Hospital 52-year-old male with painful right parotid mass.

Easy Trick to Spot Leukemia for Pediatricians

GOOD MORNING! Thursday, July Heidi Murphy, MD Leslie Carter-King, MD

Solving Medical Mysteries Deducing diagnoses from clues in the CBC. Donald S. Houston MD PhD FRCPC

Lahey Clinic Internal Medicine Residency Program: Curriculum for Hematology

What is a hematological malignancy? Hematology and Hematologic Malignancies. Etiology of hematological malignancies. Leukemias

Approaching Neutropenia in Children. SW Florida Osteopathic Medical Society: 39 th Annual Seminars in Family Practice

Polycthemia Vera (Rubra)

FBC CASES Vernon Louw Clinical Haematology 2010

Table 8.1. Epidemiology of Leukemia in the United States (2010) Annual Deaths. Mean Age. Percentage of All Leukemias (%) (Number of New Cases)

Approach to the abnormal CBC

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals

Leukocytosis - Some Learning Points

Preferred Clinical Services for Leading Age Florida August 26-27, 2015

APPROACHING TO PANCYTOPENIA

QUESTIONS OF HEMATOLOGY AND THEIR ANSWERS

Opportunities for Optimal Testing in the Myeloproliferative Neoplasms. Curtis A. Hanson, MD

Disclosures/COI. Cases in Hematopathology. Outline. Heme Path Findings Not to Miss. Normal Peripheral Smear 6/30/2016

GP Referral Guidelines. for. South Wales Cancer Network. Document Control Sheet. Specialty/Project Haematological Site Specific Group

Pathology of Hematopoietic and Lymphoid tissue

The Complete Blood Count

Leukemia and Myelodysplastic Syndromes

MYELOPROLIFARATIVE NEOPLASMS. Dr. Hasan Fahmawi, MRCP(UK), FRCP(Edin).

Lymphoma Case Scenario 1

Pharmacy Prior Authorization

The Evaluation and Classification of Anemia

FBC interpretation. Dr. Gergely Varga

CLINICAL POLICY DEPARTMENT: Medical Management DOCUMENT NAME: JakafiTM REFERENCE NUMBER: NH.PHAR.98

PNH Glossary of Terms

Index. Note: Page numbers of article titles are in boldface type.

Aplastic anamia & Sideroblastic anemia

Hematology/Oncology/BMT

Done By : WESSEN ADNAN BUTHAINAH AL-MASAEED

Contemporary perspectives and initial management of pediatric ITP. William Beau Mitchell, MD Weill Cornell Medical College New York, NY USA

July 3, The Physician Compare Team Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244

Myelodyplastic Syndromes Paul J. Shami, M.D.

Does Morphology Matter in 2017

Nicole Laferriere MD PhD FRCPC April 10, Patient Case Studies: Sticky Situations For Platelet Transfusions

Western Health Specialist Clinics Access & Referral Guidelines

UNDERSTANDING POLYCYTHEMIA VERA (PV) A guide for patients and caregivers

Myelodysplastic Syndrome Early Detection, Diagnosis, and Staging

Myelodysplastic Syndromes (MDS) Diagnosis, Treatments & Support

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation

Cytopaenias in HIV. Dr Maresce Bizaare Specialist Physician Clinical Haematology Fellow IALCH

Chronic Myeloproliferative Disorders

By Angela Gascoigne Haematology CNS Chesterfield Royal Hospital

GP CME. James Liang Consultant Haematologist. Created by: Date:

32yr old female with isolated splenomegaly and Pseudo Gaucher cells

Flow Cytometry. Bone Marrow Aspirate and Biopsy. Leukemia and Myelodysplastic Syndromes

Diagnosis / Lab Findings

The Internists Approach to Polycythemia and Implications of Uncontrolled Disease

1. Adequate diet and iron intake to prevent iron deficiency 2. Signs and symptoms of malignant disease

Flow Cytometry. Leukemia and Myelodysplastic Syndromes. Bone Marrow Aspirate and Biopsy

Chapter 3 Diseases of the Blood and Bloodforming Organs and Certain Disorders Involving the Immune Mechanism D50-D89

Pathology of Hematopoietic and Lymphoid tissue

PROBLEMS OF THE HEMATOLOGICAL SYSTEM

Thrombocytopenia: a practial approach

Deconstructing the CBC

Case History: A 45 Year Old Female Presenting with Fatigue, High Platelets and Splenomegaly. Clinical Approach, Investigations and Management

Transcription:

Division of Family Practice Platelet and WBC disorders Adrian Yee MD FRCPC Clinical hematologist Assistant Dean, undergraduate education, IMP asyee@uvic.ca

When we understand that slide, we'll have won the war.

Conflict of Interest In the last 12 months, I have received honoraria from: Celgene Boehinger-Ingelheim Lundbeck

Learning outcomes At the end of this interactive workshop, you will be able to: Develop an individualized approach to manage patients with platelets and WBC disorder. Counsel patients on management plan and arrange appropriate follow up.

Case 1: high platelets 38 year-old G1P1 F with long standing history of thrombocytosis (~700). Initiated on oral contraceptives 3 months post-partum. Presented with abdominal pain, jaundice. CT abdomen/pelvis: portal vein thrombosis/mesenteric venous thrombosis.

Management Initiate on Anticoagulation. Stop OCP Investigate causes of high platelets

Questions: What are the differential diagnoses? What are you going to inform her?

Approach to thrombocytosis History: thromboembolic complication, bleeding, bruising, constitutional symptom, adenopathy, abdomninal symptom or alteration of bowel habits. Physical: abdominal examination for?splenomegaly. Lab: Repeat CBC differential, peripheral smear, LFT, Creatinine, Ferritin, Hep B/C/HIV and abdominal ultrasound Consider JAK 2 mutation if thrombocytosis persists.

When is it an emergency? No clear cut answer unlike thrombocytopenia. It is a concern if patient has recent bleeding/thrombosis with high platelet counts.??platelet over 1500.

??JAK 2 mutation Janus kinase 2 mutation regulator of hematopoiesis. Mutation is present in 90% of patients with polycythemia vera, 60% of patients with essential thrombocythemia. Why is it important to know? New therapeutics JAK 2 inhibitor (Ruxolitinib) ASH education 2012

Management of Essential Thrombocythemia Low risk group (age less than 60 and without thrombosis): aspirin and cardiovascular risk management. High risk group: hydroxyurea and aspirin. Other option: Anagrelide Novel therapy: Ruxolitinib (JAK 2 inhibitor) B l o o d

Low platelet 32 year old M with recent viral illness. Now has easy bruising. No other symptom. On examination: no splenomegaly. Ecchymosis at the lower extremities. Lab: hemoglobin 132, WBC 7.2, Platelet 13.

Approach to low platelets What are the differential diagnoses? History: bleeding/bruising, constitutional symptom, recent infection, joint symptom, rashes. Physical examination: oral blood blister, skin, spleen, lymphadenopathy, MSK

Lab investigations CBC differential, Creatinine, Calcium, AST, ALT, Bilirubin, Hep B, Hep C, HIV. Abdominal ultrasound.? ANA, Anti DNA, Rheumotoid factor.?bone marrow biopsy

Immune thrombocytopenia purpura Treatment is recommended when platelet is less than 30. First line treatment: Prednisone/Dexamethasone, IVIG Second line: Splenectomy Third line: Rituximab, Immunosuppressive Therapy and Thrombopoietin agonist (Eltrompopag, Nplate)

Abnormal neutrophils 62 year old presented with fatigue and lightheadedness. CBC diff: Hgb 112, WBC 300, Neutrophil 160 with left shift and blast, Platelet 62.

Differential Diagnoses 1. Acute myeloid leukemia. 2. Chronic myeloid leukemia.

When it is an emergency? Hyperviscosity symptoms: headache, visual blurring, confusion, tinnitus, unusual bleeding/bruising. Total WBC > 50 if it is of myeloid lineage. Blast in the peripheral film. Severe cytopenia. Lymphocytosis = seldom causes hyperviscosity.

Chronic myeloid leukemia Rare disease: 1 in 100,000 Arises from single mutation (philadephia chromosome) Excellent prognosis with treatment (Imatinib).

Neutropenia 23 year old F presented with fatigue. No other symptom. Bloodwork: Hemoglobin 117 MCV 81 Platelets 190 WBC 0.7 and Neutrophil 0.2

Is this an emergency? Patient is unwell with fever, symptom of infection, oral ulcer, etc.. Neutrophil less than 0.5. Pancytopenia. Blast in the peripheral film.

Approach History: fever, infectious symptom, unusual bleeding/bruising, fatigue, constitutional symptom, MSK symptom, connective tissue disorder screening questions. Physical examination: oropharynx, lymphatic system, abdominal, cardiopulmonary systems.

Differential diagnoses Underproduction: Bone marrow failure- leukemias, lymphoma, myeloma, myelodysplasia, aplastic anemia, etc. Drugs: chemotherapy, methotrexate, imuran, etc. Cyclic neutropenia. Destruction: Autoimmune disease Medications: penicillin, vancomycin, levamisole Sepsis Viral infection: Hep B, C, HIV, EBV, CMV

Investigations Sometimes: Always: CBC diff, peripheral smear, creatinine, ca, LFTs, vitamin B12, SPE, urine protein electropheresis, Hep Bs Ag, Hep B core antibody, hep C and HIV Iron studies, Retic count. ANA, anti-dna, RF, ANCA More contentious: bone marrow biopsy Abdominal ultrasound

Does she need to be hospitalized? Fever Severe pancytopenia Presentation is suggestive of Acute Leukemia.

When would you be less concerned about neutropenia? Chronic neutropenia for years. Intermittent. Neutrophil is always over 1.0. Lack of symptom/infection.

Summary Develop an individualized approach to manage patients with platelets and WBC disorder. Counsel patients on management plan and arrange appropriate follow up.